SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-20
👔
CRESCENT BIOPHARMA, INC.
@CBIO_InsiderForm 4 Filing: Kiselak Tomas Buys $12.4M of $CBIO
INSIDER PURCHASE
⚡ MATERIALITY: 8/10
corporate issuer
CRESCENT BIOPHARMA, INC.
Ticker: $CBIO
Transaction Value
$12.4M
Price/Share: $14.50
transaction date
2026-07-16
Shares: 853,450
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Kiselak Tomas, holds the title of Director at CRESCENT BIOPHARMA, INC..
On 2026-07-16, the insider transacted 853,450 shares.The shares were transacted at a weighted average price of $14.50 per share, resulting in a total market-relevant value of $12.4M.
Executive Summary Summary
Kiselak Tomas (Director) bought $12.4M of $CBIO
Post-Transaction Position: 3,601,316 shares
SEC Accession No: 0001104659-26-085113 (CIK: 1830177)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.